Development of the First Two-Pore Domain Potassium Channel TWIK-Related K+ Channel 1-Selective Agonist Possessing in Vivo Antinociceptive Activity-Reference-Cited by-同舟云学术

Development of the First Two-Pore Domain Potassium Channel TWIK-Related K+ Channel 1-Selective Agonist Possessing in Vivo Antinociceptive Activity

Published:2017-01-20 Issue:3 Volume:60 Page:1076-1088
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Vivier Delphine¹,Soussia Ismail Ben²,Rodrigues Nuno¹,Lolignier Stéphane³,Devilliers Maïly³,Chatelain Franck C.²,Prival Laetitia³,Chapuy Eric³,Bourdier Geoffrey¹,Bennis Khalil¹,Lesage Florian²,Eschalier Alain³⁴,Busserolles Jérôme³,Ducki Sylvie¹^ORCID

Affiliation:

1. Université Clermont Auvergne, CNRS, SIGMA Clermont, ICCF, F-63000 Clermont-Ferrand, France

2. Labex ICST, Institut de Pharmacologie Moléculaire et Cellulaire, UMR CNRS 7275, Université Côte d’Azur, F-06560 Valbonne, France

3. Université Clermont Auvergne, Inserm, Neuro-Dol, F-63000 Clermont-Ferrand, France

4. CHU Clermont-Ferrand, Service de Pharmacologie, F-63003 Clermont-Ferrand, France

Funder

Agence Nationale de la Recherche

European Regional Development Fund

Fondation pour la Recherche Médicale

Ministère de l'Enseignement Supérieur et de la Recherche

Conseil Régional d'Auvergne

French Society for the Study and Treatment of Pain